Cipralisant

DB19761ExperimentalSmall molecule

Cipralisant is a small molecule drug. The usage of the INN stem '-isant' in the name indicates that Cipralisant is a histamine H3 receptor antagonist. Cipralisant has a monoisotopic molecular...

Formula / weight: C₁₄H₂₀N₂ · 216.328 g/mol (avg)
Code names: (-)-GT-2331

Resolves to

Compound

UNII309713XSKWCAS213027-19-1ChEMBLCHEMBL278462ChEBI748012PubChem6450823

Structure

InChIKeyCVKJAXCQPFOAIN-VXGBXAGGSA-NSMILESCC(C)(C)CCC#C[C@@H]1C[C@H]1C1=CNC=N1

Targets

Q9Y5N1HRH3

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cipralisant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account